InvestorsHub Logo
Followers 58
Posts 10035
Boards Moderated 1
Alias Born 09/21/2016

Re: sokol post# 191794

Tuesday, 05/07/2019 8:07:38 AM

Tuesday, May 07, 2019 8:07:38 AM

Post# of 458318
sokol...great additional information.

Australia
The European Medicines Agency and the European Commission have had confidentiality arrangements with the Therapeutic Goods Administration (TGA) of the Australian Government Department of Heath and Ageing since 2012, to allow the exchange of information between the parties as part of their regulatory and scientific processes. The European Union (EU) and Australia also have a mutual recognition agreement (MRA) in place on good manufacturing practice (GMP) compliance.’’

https://www.ema.europa.eu/en/human-regulatory/research-development/compliance/good-manufacturing-practice/mutual-recognition-agreements-mra
https://www.ema.europa.eu/en/human-regulatory/research-development/clinical-trials-human-medicines
https://www.ema.europa.eu/en/partners-networks/international-activities/bilateral-interactions-non-eu-regulators/Australia

Now, to round out the context: Do we suppose that the recently established AVXL+Consortium which includes private sector interest from EU, USA, ASIA, ongoing AUS helps to facilitate the macro WW CNS disease solution? Does this suggest that the days of the BP-FDA synchronous corruption exercises are behind us? Wouldn't that be nice. Little Anavex holds the KEY science required to make it all work. Lots of dots in this strategy but we can say CAVU.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News